Advertisement

Osteoporosis International

, Volume 26, Issue 3, pp 1231–1232 | Cite as

Warfarin use and fracture risk: an evidence-based mechanistic insight

  • T. Sugiyama
  • F. Kugimiya
  • S. Kono
  • Y. T. Kim
  • H. Oda
Letter

Keywords

Warfarin Fracture Risk Osteocalcin Hypophosphatemic Rickets Onset Atrial Fibrillation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Walsh JS, Newman C, Eastell R (2012) Heart drugs that affect bone. Trends Endocrinol Metab 23:163–168CrossRefPubMedGoogle Scholar
  2. 2.
    Misra D, Zhang Y, Peloquin C, Choi HK, Kiel DP, Neogi T (2014) Incident long-term warfarin use and risk of osteoporotic fractures: propensity-score matched cohort of elders with new onset atrial fibrillation. Osteoporos Int 25:1677–1684. doi: 10.1007/s00198-014-2662-0 CrossRefPubMedGoogle Scholar
  3. 3.
    Sugiyama T, Takaki T, Sakanaka K, Sadamura H, Mori K, Kato Y, Taguchi T, Saito T (2007) Warfarin-induced impairment of cortical bone material quality and compensatory adaptation of cortical bone structure to mechanical stimuli. J Endocrinol 194:213–222CrossRefPubMedGoogle Scholar
  4. 4.
    Kavukcuoglu NB, Patterson-Buckendahl P, Mann AB (2009) Effect of osteocalcin deficiency on the nanomechanics and chemistry of mouse bones. J Mech Behav Biomed Mater 2:348–354CrossRefPubMedGoogle Scholar
  5. 5.
    Rey-Sanchez P, Lavado-Garcia JM, Canal-Macias ML, Rodriguez-Dominguez MT, Bote-Mohedano JL, Pedrera-Zamorano JD (2011) Ultrasound bone mass in patients undergoing chronic therapy with oral anticoagulants. J Bone Miner Metab 29:546–551CrossRefPubMedGoogle Scholar
  6. 6.
    Sugiyama T, Kawai S (2001) Carboxylation of osteocalcin may be related to bone quality: a possible mechanism of bone fracture prevention by vitamin K. J Bone Miner Metab 19:146–149CrossRefPubMedGoogle Scholar
  7. 7.
    Sugiyama T (2013) Vitamin D and calcium supplementation to prevent fractures in adults. Ann Intern Med 159:856CrossRefPubMedGoogle Scholar
  8. 8.
    Sugiyama T, Kawai S (2004) Quantitative ultrasound, skeletal quality, and fracture risk. Lancet 363:1076–1077CrossRefPubMedGoogle Scholar
  9. 9.
    Shanbhogue VV, Hansen S, Folkestad L, Brixen K, Beck-Nielsen SS (2014) Bone geometry, volumetric density, microarchitecture and estimated bone strength assessed by HR-pQCT in adult patients with hypophosphatemic rickets. J Bone Miner Res. doi: 10.1002/jbmr.2310 PubMedGoogle Scholar
  10. 10.
    Sugiyama T, Taguchi T, Kawai S (2002) Adaptation of bone to mechanical loads. Lancet 359:1160CrossRefPubMedGoogle Scholar
  11. 11.
    Sugiyama T, Yamaguchi A, Kawai S (2002) Effects of skeletal loading on bone mass and compensation mechanism in bone: a new insight into the “mechanostat” theory. J Bone Miner Metab 20:196–200CrossRefPubMedGoogle Scholar
  12. 12.
    Jamal SA, Browner WS, Bauer DC, Cummings SR (1998) Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 128:829–832CrossRefPubMedGoogle Scholar
  13. 13.
    Caraballo PJ, Heit JA, Atkinson EJ, Silverstein MD, O’Fallon WM, Castro MR, Melton LJ 3rd (1999) Long-term use of oral anticoagulants and the risk of fracture. Arch Intern Med 159:1750–1756CrossRefPubMedGoogle Scholar
  14. 14.
    Mamdani M, Upshur RE, Anderson G, Bartle BR, Laupacis A (2003) Warfarin therapy and risk of hip fracture among elderly patients. Pharmacotherapy 23:1–4CrossRefPubMedGoogle Scholar
  15. 15.
    Pilon D, Castilloux AM, Dorais M, LeLorier J (2004) Oral anticoagulants and the risk of osteoporotic fractures among elderly. Pharmacoepidemiol Drug Saf 13:289–294CrossRefPubMedGoogle Scholar
  16. 16.
    Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF (2006) Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2. Arch Intern Med 166:241–246CrossRefPubMedGoogle Scholar
  17. 17.
    Rejnmark L, Vestergaard P, Mosekilde L (2007) Fracture risk in users of oral anticoagulants: a nationwide case-control study. Int J Cardiol 118:338–344CrossRefPubMedGoogle Scholar
  18. 18.
    Woo C, Chang LL, Ewing SK, Bauer DC, Osteoporotic Fractures in Men Study Group (2008) Single-point assessment of warfarin use and risk of osteoporosis in elderly men. J Am Geriatr Soc 56:1171–1176CrossRefPubMedCentralPubMedGoogle Scholar
  19. 19.
    Sato Y, Honda Y, Jun I (2010) Long-term oral anticoagulation therapy and the risk of hip fracture in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation. Cerebrovasc Dis 29:73–78CrossRefPubMedGoogle Scholar
  20. 20.
    Fusaro M, Tripepi G, Noale M, Plebani M, Zaninotto M, Piccoli A, Naso A, Miozzo D, Giannini S, Avolio M, Foschi A, Rizzo MA, Gallieni M, The Vertebral Fractures Vascular Calcifications Study Group (2014) Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients. Curr Vasc Pharmacol. doi: 10.2174/15701611113119990146 Google Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2014

Authors and Affiliations

  • T. Sugiyama
    • 1
  • F. Kugimiya
    • 1
  • S. Kono
    • 1
  • Y. T. Kim
    • 1
  • H. Oda
    • 1
  1. 1.Department of Orthopaedic SurgerySaitama Medical UniversityMoroyamaJapan

Personalised recommendations